Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2-day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better clinical trials which in turn will have a positive impact on services and patient outcomes.
This course is aimed at improving knowledge and skills related to clinical trial planning and design as well as the successful running of different types of clinical trials. We will offer interactive sessions coordinated by top experts in their fields. In addition, the course will offer highly interactive workshops on Good Clinical Practice (GCP certificate included), statistics, trial data interpretation and manuscript writing.
At the end of the course delegates will have improved their knowledge in:
This course will be an excellent opportunity for education, networking and creating opportunities.
Sven Wassmann, MD, PhD, FESC
Giuseppe MC Rosano, MD, PhD, FESC
This programme is organised by the ESC Working Group on Cardiovascular Pharmacotherapy and supported by an educational grant from Amgen, Daiichi Sankyo & Pfizer.
Welcome, introduction and course objectives - S. Wassmann
The ESC Working Group on Cardiovascular Pharmacotherapy - Perspectives of a Past-Chairman and Editor-in-Chief - S. Agewall
An overview of the different aspects of clinical trials - A. Niessner
Planning and running a clinical trial: the research site - players, facilities, ethics, logistics - B.S. Lewis
Planning and running a clinical trial: sponsors, CROs, adjudication and retention - B.S. Lewis
Traditional versus novel trial designing - J. Tamargo
Requirements from regulatory agencies: endpoints, comparators, type of studies - C. Ceconi
Post marketing surveillance - T. Walther
The sponsor´s viewpoint - D. Baltic
ACS / Antithrombotics - S. Wassmann
Lipidology - B.S. Lewis
Diabetes - H. Drexel
Heart failure - C. Ceconi
Observational trials and registries - G.L. Savarese
Randomised controlled trials - A. Niessner
Meta-analyses and systematic reviews - G.L. Savarese
Reading between the lines:
How to interpret clinical trial data – Examples from recent clinical trials - S. Wassmann
GCP for the busy investigator (certificate included) - D. Rolfe
Welcome and objectives - T. Walther
Diabetes trials: challenges and current directions - T. Schmidt
Interpreting meta-analyses and clinical trials: can we believe the data? - G. Savarese
This programme is supported with an educational grant by Amgen, Daiichi Sankyo & Pfizer
Our Mission: To Reduce the Burden of Cardiovascular Disease
© 2019 European Society of Cardiology. All rights reserved